Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_assertion type Assertion NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_head.
- NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_assertion description "[Epidermal growth factor receptor (EGFR), HER3, Akt, and amphiregulin have been recognized as targets for pancreatic cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_provenance.
- NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_assertion evidence source_evidence_literature NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_provenance.
- NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_assertion SIO_000772 20726858 NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_provenance.
- NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_assertion wasDerivedFrom befree-20140225 NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_provenance.
- NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_assertion wasGeneratedBy ECO_0000203 NP222369.RAq_IAPScIAhy_6_WIlSRe36aA9ibOPthzWdIhuI_Rr3A130_provenance.